Mingyuan Medicare Development controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile3 entries
2017
Regulatory concerns over company disclosures
The Securities and Futures Commission cited concerns that the 2013 annual report and several announcements contained false, incomplete or misleading information prepared under the former management.
2016
Alleged missing funds and former-management irregularities
Following a board change, the incoming directors reported suspected asset diversion and irregularities in earlier financial statements. The reported issues included a CNY396 million payment to Beijing Nong Long Investment Management for an alleged foreign-exchange service and questions surrounding an alleged CNY420 million recovery account.
2016
Corporate records and property reported missing
After the change in directorship, the company reported that a hard drive and its corporate stamp were missing from the Hong Kong office.